During the past decade, Matsuyama Shimin Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsuyama Shimin Hospital" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matsuyama Shimin Hospital" are "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Diabetic Gastroparesis" (1 trials) and "Idiopathic Gastroparesis" (1 trials). Many other conditions were trialed in "Matsuyama Shimin Hospital" in a lesser frequency.

Most popular intervention types in "Matsuyama Shimin Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matsuyama Shimin Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Matsuyama Shimin Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Matsuyama Shimin Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Matsuyama Shimin Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".